Mrs Brieanna R Breeding, APN in Conway, AR - Nurse Practitioner

Mrs Brieanna R Breeding, APN is a Nurse Practitioner - Family physician based in Conway, Arkansas. Mrs Brieanna R Breeding is licensed to practice in Arkansas (license number A03620) and her current practice location is 2100 Meadowlake Rd Ste 10, Conway, Arkansas. She can be reached at her office (for appointments etc.) via phone at (015) 133-3225.

NPI number for Mrs Brieanna R Breeding is 1427335835 and her current mailing address is 9500 Kanis Rd, Suite 101, Little Rock, Arkansas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1427335835.

Contact Information

	Mrs Brieanna R Breeding, APN
	2100 Meadowlake Rd Ste 10, Conway, AR 72032-2569
	(015) 133-3225
	(501) 513-3065

Physician's Profile

Full Name	Mrs Brieanna R Breeding
Gender	Female
Speciality	Nurse Practitioner - Family
Location	2100 Meadowlake Rd Ste 10, Conway, Arkansas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1427335835
Provider Enumeration Date: 11/14/2011
Last Update Date: 01/08/2020

Medical Identifiers

Medical identifiers for Mrs Brieanna R Breeding such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427335835	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	1427335835 (Arkansas)	Secondary
363LF0000X	Nurse Practitioner - Family	A03620 (Arkansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Brieanna R Breeding is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Brieanna R Breeding, APN 9500 Kanis Rd, Suite 101, Little Rock, AR 72205-6324 Ph: (501) 202-1902	Mrs Brieanna R Breeding, APN 2100 Meadowlake Rd Ste 10, Conway, AR 72032-2569 Ph: (015) 133-3225

News Archive

Managing overwhelming multiple medications, Medco offers free guide for America's seniors

America's seniors are being overwhelmed by the number of prescription drugs they take on a daily basis. According to a new national survey of more than 1,000 people ages 65 and older who use medications, more than half (51 percent) take at least five different prescription drugs regularly and one in four take between 10 and 19 pills each day.

SCENESSE reduces, prevents phototoxic reactions experienced by EPP patients in Phase III trial

A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to live in the shadows.

Researchers show how protein fortilin promotes growth of cancer cells

Researchers have shown for the first time that the protein fortilin promotes growth of cancer cells by binding to and rendering inert protein p53, a known tumor suppressor. This finding by researchers at the University of Texas Medical Branch may lead to treatments for a range of cancers and atherosclerosis, which p53 also helps prevent, and appears in the current print issue of the Journal of Biological Chemistry.

Report offers insight into loneliness and social isolation in older adults during COVID-19 pandemic

A joint report published by researchers at the Irish Longitudinal Study on Ageing (TILDA) and ALONE examines issues of loneliness and social isolation in older adults.

Alcon second-quarter adjusted EPS increases 14.4% to $2.22 per share

The Alcon Independent Director Committee noted today that Alcon once again delivered strong earnings in the second quarter of 2010. Alcon's 2Q 2010 Adjusted EPS of $2.22 per share represented a year-over-year growth rate of 14.4% and exceeded Wall Street's mean consensus estimate of $2.03 per share by 9.4%. Alcon's strong EPS growth was driven by an 11.3% increase in organic sales resulting, in part, from a 22.3% increase in advanced technology intraocular lens sales, a 17.2% increase in glaucoma sales and a 24.2% increase in emerging market sales.

Mrs Brieanna R Breeding, APN - Nurse Practitioner in Conway, AR